Biosynthetic pathways and the role of the mas receptor in the effects of angiotensin-(1-7) in smooth muscles

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Fressatto De Godoy, Marcio Augusto ^a   Pernomian, Larissa ^b   De Oliveira, Ana Maria ^b   Rattan, Satish ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7]; CAPTOPRIL; CARBOXYPEPTIDASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; LISINOPRIL; MEMBRANE METALLOENDOPEPTIDASE; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR MAS; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIHYPERTENSIVE ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ATHEROGENESIS; BINDING SITE; CARDIOVASCULAR SYSTEM; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRACT FUNCTION; GENE DELETION; HEART PROTECTION; HEART RATE; HOMEOSTASIS; HUMAN; IN VITRO STUDY; MOLECULAR MECHANICS; MUSCLE RELAXATION; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE; VASCULAR TISSUE;

EID: 84868290757     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/121740     Document Type: Review

References (62)

1. Goodfriend T. L., Angiotensins. A family that grows from within. Hypertension 1991 17 2 139 140 2-s2.0-0026083052
2. Timmermans P. B., Wong P. C., Chiu A. T., Herblin W. F., Benfield P., Carini D. J., Lee R. J., Wexler R. R., Saye J. A. M., Smith R. D., Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacological Reviews 1993 45 2 205 251 2-s2.0-0027208070 (Pubitemid 23191415)
3. Schiavone M. T., Khosla M. C., Ferrario C. M., Angiotensin-[17]: evidence for novel actions in the brain. Journal of Cardiovascular Pharmacology 1990 16 4, supplement S19 S24 2-s2.0-0025047759 (Pubitemid 20343188)
4. Kohara K., Brosnihan K. B., Chappell M. C., Khosla M. C., Ferrario C. M., Angiotensin-(17). A member of circulating angiotensin peptides. Hypertension 1991 17 2 131 138 2-s2.0-0026073830
5. Page I. H., Bumpus F. M., Angiotensin. Physiological reviews 1961 41 331 390 2-s2.0-0010910242
6. Tonnaer J. A., Engels G. M. H., Wiegant V. M., Proteolytic conversion of angiotensins in rat brain tissue. European Journal of Biochemistry 1983 131 2 415 421 2-s2.0-0020640185 (Pubitemid 13129076)
7. Fitzsimons J. T., The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon. Journal of Physiology 1971 214 2 295 303 2-s2.0-0015041538
8. Santos R. A. S., Brosnihan K. B., Chappell M. C., Pesquero J., Chernicky C. L., Greene L. J., Ferrario C. M., Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension 1988 11 2 I153 I157 2-s2.0-0023924404
9. Schiavone M. T., Santos R. A. S., Brosnihan K. B., Khosla M. C., Ferrario C. M., Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(17) heptapeptide. Proceedings of the National Academy of Sciences of the United States of America 1988 85 11 4095 4098 2-s2.0-0000254274
10. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R. E., Acton S., A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 19. Circulation research 2000 87 5 E1 E9 2-s2.0-0038053724
11. Tipnis S. R., Hooper N. M., Hyde R., Karran E., Christie G., Turner A. J., A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. Journal of Biological Chemistry 2000 275 43 33238 33243 2-s2.0-0034721906 10.1074/jbc.M002615200
12. Igase M., Strawn W. B., Gallagher P. E., Geary R. L., Ferrario C. M., Angiotensin II at1 receptors regulate ACE2 and angiotensin-(17) expression in the aorta of spontaneously hypertensive rats. American Journal of Physiology 2005 289 3 H1013 H1019 2-s2.0-23944472129 10.1152/ajpheart.00068.2005 (Pubitemid 41208941)
13. Lavrentyev E. N., Estes A. M., Malik K. U., Mechanism of high glucose-induced angiotensin II production in rat vascular smooth muscle cells. Circulation Research 2007 101 5 455 464 2-s2.0-34548319203 10.1161/CIRCRESAHA. 107.151852 (Pubitemid 47347876)
14. Lavrentyev E. N., Malik K. U., High glucose-induced Nox1-derived superoxides downregulate PKC- β II, which subsequently decreases ACE2 expression and ANG(17) formation in rat VSMCs. American Journal of Physiology 2009 296 1 H106 H118 2-s2.0-58149483372 10.1152/ajpheart.00239.2008
15. Rentzsch B., Todiras M., Iliescu R., Popova E., Campos L. A., Oliveira M. L., Baltatu O. C., Santos R. A., Bader M., Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 2008 52 5 967 973 2-s2.0-55949126600 10.1161/HYPERTENSIONAHA.108.114322
16. De Godoy M. A. F., Dunn S., Rattan S., Evidence for the role of angiotensin II biosynthesis in the rat internal anal sphincter tone. Gastroenterology 2004 127 1 127 138 2-s2.0-3242721626 10.1053/j.gastro.2004.03. 056 (Pubitemid 38962281)
17. Olszanecki R., Madej J., Suski M., Gebska A., Bujak-Gizycka B., Korbut R., Angiotensin metabolism in rat stomach wall: prevalence of angiotensin-17 formation. Journal of Physiology and Pharmacology 2009 60 1 191 196 2-s2.0-65949091144
18. Harmer D., Gilbert M., Borman R., Clark K. L., Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Letters 2002 532 1-2 107 110 2-s2.0-0037021454 10.1016/S0014- 5793(02)03640-2 (Pubitemid 35375876)
19. Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., Godbout K., Parsons T., Baronas E., Hsieh F., Acton S., Patane M., Nichols A., Tummino P., Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. Journal of Biological Chemistry 2002 277 17 14838 14843 2-s2.0-18544378161 10.1074/jbc.M200581200 (Pubitemid 34952556)
20. Rice G. I., Thomas D. A., Grant P. J., Turner A. J., Hooper N. M., Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochemical Journal 2004 383 1 45 51 2-s2.0-6344246036 10.1042/BJ20040634 (Pubitemid 39389449)
21. Towler P., Staker B., Prasad S. G., Menon S., Tang J., Parsons T., Ryan D., Fisher M., Williams D., Dales N. A., Patane M. A., Pantoliano M. W., ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. Journal of Biological Chemistry 2004 279 17 17996 18007 2-s2.0-2342418543 10.1074/jbc.M311191200 (Pubitemid 38560569)
22. Zisman L. S., Meixell G. E., Bristow M. R., Canver C. C., Angiotensin-(17) formation in the intact human heart: in vivo dependence on angiotensin II as substrate. Circulation 2003 108 14 1679 1681 2-s2.0-0141988867 10.1161/01.CIR.0000094733.61689.D4 (Pubitemid 37243653)
23. Chappell M. C., Tallant E. A., Brosnihan K. B., Ferrario C. M., Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line. Peptides 1990 11 2 375 380 2-s2.0-0025213980 10.1016/0196-9781(90) 90095-M (Pubitemid 20144909)
24. Santos R. A. S., Brosnihan K. B., Jacobsen D. W., DiCorleto P. E., Ferrario C. M., Production of angiotensin-(17) by human vascular endothelium. Hypertension 1992 19 2, supplement II56 II61 2-s2.0-0026513413
25. Yamamoto K., Chappell M. C., Brosnihan K. B., Ferrario C. M., In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 1992 19 6 692 696 2-s2.0-0026605307
26. Chappell M. C., Tallant E. A., Brosnihan K. B., Ferrario C. M., Conversion of angiotensin i to angiotensin-(17) by thimet oligopeptidase (EC 3.4.24.15) in vascular smooth muscle cells. Journal of Vascular Medicine and Biology 1994 5 4 129 137 2-s2.0-0028631453
27. Kohara K., Brosnihan K. B., Ferrario C. M., Angiotensin(17) in the spontaneously hypertensive rat. Peptides 1993 14 5 883 891 2-s2.0-0027368871 10.1016/0196-9781(93)90063-M (Pubitemid 23297692)
28. Luque M., Martin P., Martell N., Fernandez C., Brosnihan K. B., Ferrario C. M., Effects of captopril related to increased levels of prostacyclin and angiotensin-(17) in essential hypertension. Journal of Hypertension 1996 14 6 799 805 2-s2.0-0029974215 10.1097/00004872-199606000-00017 (Pubitemid 26187416)
29. Chappell M. C., Pirro N. T., Sykes A., Ferrario C. M., Metabolism of angiotensin-(17) by angiotensin-converting enzyme. Hypertension 1998 31 1 362 367 2-s2.0-0031600505
30. Deddish P. A., Marcic B., Jackman H. L., Wang H. Z., Skidgel R. A., Erdös E. G., N-domain-specific substrate and c-domain inhibitors of angiotensin- converting enzyme angiotensin-(17) and keto-ace. Hypertension 1998 31 4 912 917 2-s2.0-0031954590 (Pubitemid 28185567)
31. Lovren F., Pan Y., Quan A., Teoh H., Wang G., Shukla P. C., Levitt K. S., Oudit G. Y., Al-Omran M., Stewart D. J., Slutsky A. S., Peterson M. D., Backx P. H., Penninger J. M., Verma S., Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. American Journal of Physiology 2008 295 4 H1377 H1384 2-s2.0-57049183645 10.1152/ajpheart.00331.2008
32. Thomas M. C., Pickering R. J., Tsorotes D., Koitka A., Sheehy K., Bernardi S., Toffoli B., Nguyen-Huu T. P., Head G. A., Fu Y., Chin-Dusting J., Cooper M. E., Tikellis C., Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circulation Research 2010 107 7 888 897 2-s2.0-77958001190 10.1161/CIRCRESAHA.110.219279
33. Campagnole-Santos M. J., Diz D. I., Santos R. A. S., Khosla M. C., Brosnihan K. B., Ferrario C. M., Cardiovascular effects of angiotensin-(17) injected into the dorsal medulla of rats. American Journal of Physiology 1989 257 1 H324 H329 2-s2.0-0024397233
34. Campagnole-Santos M. J., Heringer S. B., Batista E. N., Khosla M. C., Santos R. A. S., Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. American Journal of Physiology 1992 263 1 R89 R94 2-s2.0-0026632699
35. Benter I. F., Ferrario C. M., Morris M., Diz D. I., Antihypertensive actions of angiotensin-(17) in spontaneously hypertensive rats. American Journal of Physiology 1995 269 1 H313 H319 2-s2.0-0029129342
36. Benter I. F., Diz D. I., Ferrario C. M., Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(17). Hypertension 1995 26 6 1138 1144 2-s2.0-0028801354
37. Iyer S. N., Chappell M. C., Averill D. B., Diz D. I., Ferrario C. M., Vasodepressor actions of angiotensin-(17) unmasked during combined treatment with lisinopril and losartan. Hypertension 1998 31 2 699 705 2-s2.0-0031935350
38. Li P., Chappell M. C., Ferrario C. M., Brosnihan K. B., Angiotensin-(17) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 1997 29 1 394 400 2-s2.0-0031034312 (Pubitemid 27074074)
39. Meng W., Busija D. W., Mayhan W. G., Comparative effects of angiotensin-(17) and angiotensin II on piglet pial arterioles. Stroke 1993 24 12 2041 2045 2-s2.0-0027371196 (Pubitemid 23352740)
40. Pörsti I., Barra A. T., Busse R., Hecker M., Release of nitric oxide by angiotensin-(17) from porcine coronary endothelium: implications for a novel angiotensin receptor. British Journal of Pharmacology 1994 111 3 652 654 2-s2.0-0028275331 (Pubitemid 24151646)
41. Brosnihan K. B., Li P., Ferrario C. M., Angiotensin-(17) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996 27 3 523 528 2-s2.0-0029926375 (Pubitemid 26086221)
42. Ren Y., Garvin J. L., Carretero O. A., Vasodilator action of angiotensin-(17) on isolated rabbit afferent arterioles. Hypertension 2002 39 3 799 802 2-s2.0-0036194890 10.1161/hy0302.104673 (Pubitemid 34252879)
43. Zhi J. M., Chen R. F., Wang J., Jiao X. Y., Zhao R. R., Comparative studies of vasodilating effects of angiotensin-(17) on the different vessels. Acta physiologica Sinica 2004 56 6 730 734 2-s2.0-33746048878
44. Sampaio W. O., Dos Santos R. A. S., Faria-Silva R., Da Mata Machado L. T., Schiffrin E. L., Touyz R. M., Angiotensin-(17) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007 49 1 185 192 2-s2.0-33847018997 10.1161/01.HYP.0000251865. 35728.2f (Pubitemid 46360359)
45. Sampaio W. O., De Castro C. H., Santos R. A. S., Schiffrin E. L., Touyz R. M., Angiotensin-(17) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 2007 50 6 1093 1098 2-s2.0-36448975192 10.1161/HYPERTENSIONAHA.106.084848 (Pubitemid 350172931)
46. Touyz R. M., Reactive oxygen species and angiotensin II signaling in vascular cellsimplications in cardiovascular disease. Brazilian Journal of Medical and Biological Research 2004 37 8 1263 1273 2-s2.0-4444333896 (Pubitemid 39172561)
47. Szabó C., Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. British Journal of Pharmacology 2009 156 5 713 727 2-s2.0-64149103180 10.1111/j.1476-5381.2008.00086.x
48. De Vriese A. S., Verbeuren T. J., Van De Voorde J., Lameire N. H., Vanhoutte P. M., Endothelial dysfunction in diabetes. British Journal of Pharmacology 2000 130 5 963 974 2-s2.0-0033920419 (Pubitemid 30453529)
49. Freeman E. J., Chisolm G. M., Ferrario C. M., Tallant E. A., Angiotensin-(17) inhibits vascular smooth muscle cell growth. Hypertension 1996 28 1 104 108 2-s2.0-0029957780 (Pubitemid 26231097)
50. Tallant E. A., Clark M. A., Molecular mechanisms of inhibition of vascular growth by angiotensin-(17). Hypertension 2003 42 4 574 579 2-s2.0-0141893551 10.1161/01.HYP.0000090322.55782.30 (Pubitemid 37237356)
51. Strawn W. B., Ferrario C. M., Tallant E. A., Angiotensin-(17) reduces smooth muscle growth after vascular injury. Hypertension 1999 33 1 207 211 2-s2.0-0032898753 (Pubitemid 29065661)
52. Langeveld B., Van Gilst W. H., Tio R. A., Zijlstra F., Roks A. J. M., Angiotensin-(17) attenuates neointimal formation after stent implantation in the rat. Hypertension 2005 45 1 138 141 2-s2.0-11244253741 10.1161/01.HYP. 0000149382.83973.c2 (Pubitemid 40066428)
53. Walter D. H., Cejna M., Diaz-Sandoval L., Willis S., Kirkwood L., Stratford P. W., Tietz A. B., Kirchmair R., Silver M., Curry C., Wecker A., Yoon Y. S., Heidenreich R., Hanley A., Kearney M., Tio F. O., Kuenzler P., Isner J. M., Losordo D. W., Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 2004 110 1 36 45 2-s2.0-3042828271 10.1161/01.CIR.0000133324.38115.0A (Pubitemid 38885702)
54. Langeveld B. E., Henning R. H., De Smet B. J. G. L., Zijlstra F., Driessen A., Tijsma E., Van Gilst W. H., Roks A. J. M., Rescue of arterial function by angiotensin-(17): towards improvement of endothelial function by drug-eluting stents. Netherlands Heart Journal 2008 16 9 293 298 2-s2.0-58149235049
55. Kucharewicz I., Pawlak R., Matys T., Pawlak D., Buczko W., Antithrombotic effect of captopril and losartan is mediated by angiotensin-(17). Hypertension 2002 40 5 774 779 2-s2.0-0036841147 10.1161/01.HYP.0000035396.27909.40 (Pubitemid 35278618)
56. Tesanovic S., Vinh A., Gaspari T. A., Casley D., Widdop R. E., Vasoprotective and atheroprotective effects of angiotensin (17) in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 8 1606 1613 2-s2.0-77955175630 10.1161/ATVBAHA.110.204453
57. Young D., Waitches G., Birchmeier C., Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 1986 45 5 711 719 2-s2.0-0022536710 (Pubitemid 16063134)
58. Santos R. A. S., Simoes e Silva A. C., Maric C., Silva D. M. R., Machado R. P., De Buhr I., Heringer-Walther S., Pinheiro S. V. B., Lopes M. T., Bader M., Mendes E. P., Lemos V. S., Campagnole-Santos M. J., Schultheiss H. P., Speth R., Walther T., Angiotensin-(17) is an endogenous ligand for the G protein-coupled receptor Mas. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8258 8263 2-s2.0-0037478671 10.1073/pnas.1432869100 (Pubitemid 36842532)
59. Santos R. A. S., Campagnole-Santos M. J., Baracho N. C. V., Fontes M. A. P., Silva L. C. S., Neves L. A. A., Oliveira D. R., Caligiorne S. M., Rodrigues A. R. V., Gropen C., Carvalho W. S., Silva A. C. S. E., Khosla M. C., Characterization of a new angiotensin antagonist selective for angiotensin-(17): evidence that the actions of angiotensin-(17) are mediated by specific angiotensin receptors. Brain Research Bulletin 1994 35 4 293 298 2-s2.0-0028061656 10.1016/0361-9230(94)90104-X (Pubitemid 24332669)
60. Cangussu L. M., de Castro U. G. M., Machado R. D. P., Silva M. E., Ferreira P. M., dos Santos R. A. S., Campagnole-Santos M. J., Alzamora A. C., Angiotensin-(17) antagonist, A-779, microinjection into the caudal ventrolateral medulla of renovascular hypertensive rats restores baroreflex bradycardia. Peptides 2009 30 10 1921 1927 2-s2.0-70349325847 10.1016/j.peptides.2009.06.028
61. Tirapelli C. R., Fukada S. Y., de Godoy M. A. F., de Oliveira A. M., Analysis of the mechanisms underlying the vasorelaxant action of angiotensin II in the isolated rat carotid. Life Sciences 2006 78 23 2676 2682 2-s2.0-33646496802 10.1016/j.lfs.2005.10.031
62. Zhang F., Hu Y., Xu Q., Ye S., Different effects of angiotensin ii and angiotensin-(17) on vascular smooth muscle cell proliferation and migration. PLoS ONE 2010 5 8 2-s2.0-77957881110 10.1371/journal.pone.0012323 e12323